» Articles » PMID: 34077540

Neoplastic and Immune Single-cell Transcriptomics Define Subgroup-specific Intra-tumoral Heterogeneity of Childhood Medulloblastoma

Abstract

Background: Medulloblastoma (MB) is a heterogeneous disease in which neoplastic cells and associated immune cells contribute to disease progression. We aimed to determine the influence of neoplastic and immune cell diversity on MB biology in patient samples and animal models.

Methods: To better characterize cellular heterogeneity in MB we used single-cell RNA sequencing, immunohistochemistry, and deconvolution of transcriptomic data to profile neoplastic and immune populations in patient samples and animal models across childhood MB subgroups.

Results: Neoplastic cells cluster primarily according to individual sample of origin which is influenced by chromosomal copy number variance. Harmony alignment reveals novel MB subgroup/subtype-associated subpopulations that recapitulate neurodevelopmental processes, including photoreceptor and glutamatergic neuron-like cells in molecular subgroups GP3 and GP4, and a specific nodule-associated neuronally differentiated subpopulation in the sonic hedgehog subgroup. We definitively chart the spectrum of MB immune cell infiltrates, which include subpopulations that recapitulate developmentally related neuron-pruning and antigen-presenting myeloid cells. MB cellular diversity matching human samples is mirrored in subgroup-specific mouse models of MB.

Conclusions: These findings provide a clearer understanding of the diverse neoplastic and immune cell subpopulations that constitute the MB microenvironment.

Citing Articles

Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179.

Li Y, Lim C, Dismuke T, Malawsky D, Oasa S, Bruce Z Nat Commun. 2025; 16(1):1091.

PMID: 39904981 PMC: 11794477. DOI: 10.1038/s41467-024-54861-3.


Sonic hedgehog medulloblastoma cells in co-culture with cerebellar organoids converge towards in vivo malignant cell states.

van Essen M, Nicheperovich A, Schuster-Bockler B, Becker E, Jacob J Neurooncol Adv. 2025; 7(1):vdae218.

PMID: 39896075 PMC: 11783571. DOI: 10.1093/noajnl/vdae218.


Single-Cell RNA Sequencing Reveals LEF1-Driven Wnt Pathway Activation as a Shared Oncogenic Program in Hepatoblastoma and Medulloblastoma.

Desterke C, Fu Y, Bonifacio-Mundaca J, Monge C, Pineau P, Mata-Garrido J Curr Oncol. 2025; 32(1).

PMID: 39851951 PMC: 11763369. DOI: 10.3390/curroncol32010035.


High cellular plasticity state of medulloblastoma local recurrence and distant dissemination.

Liu H, Zhang J, Wang Z, Wang W, Han D, Chen X Cell Rep Med. 2025; 6(1):101914.

PMID: 39809264 PMC: 11866544. DOI: 10.1016/j.xcrm.2024.101914.


Single-cell multi-omics analysis identifies metabolism-linked epigenetic reprogramming as a driver of therapy-resistant medulloblastoma.

Veo B, Wang D, DeSisto J, Pierce A, Vibhakar R Res Sq. 2024; .

PMID: 39711559 PMC: 11661367. DOI: 10.21203/rs.3.rs-5522707/v1.


References
1.
Vladoiu M, El-Hamamy I, Donovan L, Farooq H, Holgado B, Sundaravadanam Y . Childhood cerebellar tumours mirror conserved fetal transcriptional programs. Nature. 2019; 572(7767):67-73. PMC: 6675628. DOI: 10.1038/s41586-019-1158-7. View

2.
Schafer D, Stevens B . Microglia Function in Central Nervous System Development and Plasticity. Cold Spring Harb Perspect Biol. 2015; 7(10):a020545. PMC: 4588063. DOI: 10.1101/cshperspect.a020545. View

3.
Northcott P, Korshunov A, Witt H, Hielscher T, Eberhart C, Mack S . Medulloblastoma comprises four distinct molecular variants. J Clin Oncol. 2010; 29(11):1408-14. PMC: 4874239. DOI: 10.1200/JCO.2009.27.4324. View

4.
Ocasio J, Bates R, Rapp C, Gershon T . GSK-3 modulates SHH-driven proliferation in postnatal cerebellar neurogenesis and medulloblastoma. Development. 2019; 146(20). PMC: 6826032. DOI: 10.1242/dev.177550. View

5.
Pei Y, Liu K, Wang J, Garancher A, Tao R, Esparza L . HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma. Cancer Cell. 2016; 29(3):311-323. PMC: 4794752. DOI: 10.1016/j.ccell.2016.02.011. View